Mark Lawler

Professor

Associate Pro-Vice-Chancellor and Professor of Digital Health, School of Medicine, Dentistry and Biomedical Sciences

Phone+44 (0)28 9097 5883
Emailmark.lawler@qub.ac.uk

90 Lisburn Road
United Kingdom

Accepting PhD Students

PhD projects

Prof Lawler has an international reputation in cancer research and recently received the prestigious 2018 European Health Award. His research focuses on developing a molecular understanding of cancer to improve patient care, including through precision medicine. approaches As Associate Director of Health Data Research Wales Northern Ireland, he also has a keen interest in health data research with particular relevance to cancer. Additionally, his research into cancer inequalities has been influential at both national and European levels

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Mark Lawler is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

11 Active

R1140CNR: Digital Innovation Hub Programme - DATA CAN
Lawler, M., Gavin, A., James, J. & Salto-Tellez, M.
02/01/2020 → …
Project: Research
R2551CNR: ACRCelerate: Colorectal Cancer Stratified Medicine Network
Dunne, P. & Lawler, M.
03/01/2019 → …
Project: Research
R1917CNR: Health Data Research UK (HDR UK)
Lawler, M., Blayney, J., Coleman, H., Dunne, P., Heaney, L., Kee, F., McArt, D., Nikolopoulos, D., O'Reilly, D., Overton, I., Salto-Tellez, M. & Woods, R.
29/10/2018 → …
Project: Research
S2455MGT: KTP/ DIACEUTICS LIMITED
French, D. & Lawler, M.
01/08/2018 → …
Project: ktp
R1869CNR: Facilitating data integration to empower Colorectal Cancer (CRC) discovery research
Lawler, M. & Dunne, P.
27/03/2018 → …
Project: Research

186 Article
8 Review article
7 Comment/debate
5 Poster
More

In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Malla, S. B., Fisher, D. J., Domingo, E., Blake, A., Hassanieh, S., Redmond, K. L., Richman, S. D., Youdell, M., Walker, S. M., Logan, G. E., Chatzipli, A., Amirkhah, R., Humphries, M. P., Craig, S. G., McDermott, U., Seymour, M. T., Morton, D. G., Quirke, P., West, N. P., Salto-Tellez, M. & 12 others, Kennedy, R. D., Johnston, P. G., Tomlinson, I., Koelzer, V. H., Campo, L., Kaplan, R. S., Longley, D. B., Lawler, M., Maughan, T. S., Brown, L. C., Dunne, P. D. & Consortium, S. C., 01 Jan 2021, In: Clinical Cancer Research. 27, 1, p. 288-300
Research output: Contribution to journal › Article › peer-review
Predicting endoscopic activity recovery in England after COVID-19: a national analysis
Ho, K. M. A., Banerjee, A., Lawler, M., Rutter, M. D. & Lovat, L. B., 11 Mar 2021, In: The Lancet Gastroenterology & Hepatology.
Research output: Contribution to journal › Article › peer-review
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer
Variant Interpretation for Cancer Consortium, 03 Apr 2020, In: Nature Genetics. 52, 4, p. 448-457 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
16 Citations (Scopus)

30 Downloads (Pure)
Cancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis?
Vrdoljak, E., Sullivan, R. & Lawler, M., Jun 2020, In: European Journal of Cancer. 132, p. 98-99 2 p.
Research output: Contribution to journal › Letter › peer-review

13 Citations (Scopus)
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
Sud, A., Torr, B., Jones, M., Broggio, J., Scott, S., Loveday, C., Garrett, A., Gronthoud, F., Nicol, D. L., Jhanji, S., Boyce, S. A., Williams, M., Riboli, E., Muller, D. C., Kipps, E., Larkin, J., Navani, N., Swanton, C., Lyratzopoulos, G., McFerran, E. & 3 others, Lawler, M., Houlston, R. & Turnbull, C., 01 Aug 2020, In: The Lancet Oncology. 21, 8, p. 1035-1044 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
52 Citations (Scopus)

132 Downloads (Pure)

Ely Lilly Prize
Lawler, Mark (Recipient), 1993
Prize: Prize (including medals and awards)
European Health Award
Lawler, Mark (Recipient), 2018
Prize: Prize (including medals and awards)
FRC Path
Lawler, Mark (Recipient), 2006
Prize: Fellowship awarded competitively
Graves |Medal for Medical Research
Lawler, Mark (Recipient), 2004
Prize: National/international honour
Irish Association for Cancer Research outstanding contribution to cancer research and medicine award
Lawler, Mark (Recipient), 2021
Prize: Prize (including medals and awards)

1 Public lecture/debate/seminar

‘Leading Through a Pandemic’ Michael Dowling, President and CEO, Northwell Health
Joanne Murphy (Contributor), Michael Dowling (Keynote speaker) & Mark Lawler (Host)
23 Feb 2021
Activity: Talk or presentation types › Public lecture/debate/seminar

Our role in advocating for cancer patients cannot be underestimated
Ethna McFerran & Mark Lawler
07/08/2020
1 Media contribution
Press/Media: Expert Comment
Coronavirus could lead to thousands more cancer deaths
Ethna McFerran & Mark Lawler
21/07/2020
1 Media contribution
Press/Media: Other